ArrowMark Colorado Holdings’s 10x Genomics TXG Stock Holding History

ArrowMark Colorado Holdings’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$619K	Hold	16,143	–	–	0.03%	266
2026 Q1	$343K	Hold	16,143	–	–	0.01%	277
2025 Q4	$263K	Hold	16,143	–	–	0.01%	302
2025 Q3	$189K	Hold	16,143	–	–	﹤0.01%	300
2025 Q2	$187K	Hold	16,143	–	–	﹤0.01%	298
2025 Q1	$141K	Hold	16,143	–	–	﹤0.01%	294
2024 Q4	$232K	Hold	16,143	–	–	﹤0.01%	298
2024 Q3	$365K	Hold	16,143	–	–	﹤0.01%	281
2024 Q2	$314K	Hold	16,143	–	–	﹤0.01%	300
2024 Q1	$606K	Hold	16,143	–	–	0.01%	285
2023 Q4	$903K	Hold	16,143	–	–	0.01%	263
2023 Q3	$666K	Buy	+16,143	New	+$840K	0.01%	269
2020 Q1	–	Sell	-99,845	Closed	-$7.61M	–	324
2019 Q4	$7.61M	Buy	99,845 +1,569	+2%	+$94.3K	0.07%	174
2019 Q3	$4.95M	Buy	+98,276	New	+$5.44M	0.05%	195

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ArrowMark Colorado Holdings's TXG Position: Q2 2026 in Review

ArrowMark Colorado Holdings held its 10x Genomics (TXG) position steady in Q2 2026 at 16,143 shares worth $619K. The position accounts for 0.03% of the portfolio, ranked #266.

ArrowMark Colorado Holdings first reported a position in TXG in Q3 2019 and has held it in 14 quarters since. The position peaked at $7.61M in Q4 2019. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

ArrowMark Colorado Holdings held 16,143 shares of 10x Genomics worth $619K as of Q2 2026.
ArrowMark Colorado Holdings left its 10x Genomics share count unchanged in Q2 2026.
10x Genomics made up 0.03% of ArrowMark Colorado Holdings's portfolio in Q2 2026, its #266 holding.
ArrowMark Colorado Holdings first reported a position in 10x Genomics in Q3 2019 and has held it in 14 quarters since.
ArrowMark Colorado Holdings's 10x Genomics position peaked at $7.61M in Q4 2019.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.